Metastatic breast cancer survivor Myriam Saenz, who is currently undergoing breast cancer treatment at MD Anderson in Sugar Land, says her cancer diagnosis and cancer treatment have changed her life profoundly. But her children have helped her get through this difficult time in her life.

Learn more about MD Anderson in Sugar Land: https://www.mdanderson.org/abo....ut-md-anderson/our-l

Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/Requ....estAppointment?cmpid

Ashley Fernandez was diagnosed with metastatic breast cancer (MBC) when she was just 31 years old. She was on a trip with her daughter and mother, who lived in a different city, when she learned of her diagnosis. Ashley felt like she had the people she needed with her to process the devastating news. Watch Ashley tell her story and how she lives with MBC by drawing emotional strength from sunshine, faith and family. ow she lives with MBC by drawing emotional strength from sunshine, faith and family.

Learn more at https://MBC.komen.org or donate for MBC research at https://komen.org/MBCdonate.

A new study published in the New England Journal of Medicine says treating HER2-negative breast cancer patients with the existing cancer drug, Enhertu, can elongate their lives by five or six months.
READ MORE: https://gma.abc/3aLwMDc


SUBSCRIBE to GMA's YouTube page:
https://bit.ly/2Zq0dU5

SIGN UP to get the daily GMA Wake-Up Newsletter:
https://gma.abc/2Vzcd5j

VISIT GMA's homepage:
https://www.goodmorningamerica.com

FOLLOW GMA:
TikTok: https://tiktok.com/@gma
Instagram: https://instagram.com/GoodMorningAmerica
Facebook: https://facebook.com/GoodMorningAmerica
Twitter: https://twitter.com/gma


#GMA #BreastCancer #Enhertu #Medicine #chemotherapy

Meet Vanessa, age 45, from San Jose, California. When she was first diagnosed with metastatic breast cancer (MBC), she couldn’t wrap her head around the news. Though initially worried more about her loved ones, Vanessa has accepted her diagnosis and is determined to advocate for herself and others within the LGBTQ+ and MBC communities. Vanessa hopes that by sharing her story, she can spread awareness about the long-term effects of MBC and keep advocating for the MBC community.

Vanessa’s story is featured as part of the #ThisIsMBC Imagine campaign, brought to you by and in collaboration with METAvivor and Eisai Inc.

To join the conversation, follow #ThisIsMBC on Twitter, Instagram, and Facebook.

To learn more about MBC, please visit: www.metavivor.org or www.mbcinfocenter.com

Licensed music:
V8YOXFYCFGXCHKCT
LZ7PRZIRQ4UCWSUB
VFZEZBFTVFNZPLIT
7JFV7AZQNJZWIDMF
IQEG8S5KNROWJHHU
AJ3EBPQLTH0CZEXY
8Z6UH5DRIXHYXDKA

Ashley Fernandez was diagnosed with metastatic breast cancer (MBC) when she was just 31 years old. She was on a trip with her daughter and mother, who lived in a different city, when she learned of her diagnosis. Ashley felt like she had the people she needed with her to process the devastating news. Watch Ashley tell her story and how she lives with MBC by drawing emotional strength from sunshine, faith and family. ow she lives with MBC by drawing emotional strength from sunshine, faith and family.

Learn more at https://MBC.komen.org or donate for MBC research at https://komen.org/MBCdonate.

A new study published in the New England Journal of Medicine says treating HER2-negative breast cancer patients with the existing cancer drug, Enhertu, can elongate their lives by five or six months.
READ MORE: https://gma.abc/3aLwMDc


SUBSCRIBE to GMA's YouTube page:
https://bit.ly/2Zq0dU5

SIGN UP to get the daily GMA Wake-Up Newsletter:
https://gma.abc/2Vzcd5j

VISIT GMA's homepage:
https://www.goodmorningamerica.com

FOLLOW GMA:
TikTok: https://tiktok.com/@gma
Instagram: https://instagram.com/GoodMorningAmerica
Facebook: https://facebook.com/GoodMorningAmerica
Twitter: https://twitter.com/gma


#GMA #BreastCancer #Enhertu #Medicine #chemotherapy

It is important to know that not all metastatic breast cancers are the same. Testing helps plan treatment designed just for you. This brief animated video explains different tests to determine what type of metastatic breast cancer you might have and how different features of a tumor can lead to different types of treatment.

Please talk with your doctor and see the NCCN Guidelines for Patients: Metastatic Breast Cancer (https://www.nccn.org/patientre....sources/patient-reso for more information.

This video is for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to determine the right course of treatment for you.

Supporters:
This video is presented with support from the NCCN Foundation and by contributions from the corporate supporter of this video, Pfizer Inc.

NCCN Guidelines for Patients are developed independently and corporate supporters do not participate in their development.

________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit www.nccn.org/patients/foundation

________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.

Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCN....video?sub_confirmati

Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/

Metastatic breast cancer survivor Myriam Saenz, who is currently undergoing breast cancer treatment at MD Anderson in Sugar Land, says her cancer diagnosis and cancer treatment have changed her life profoundly. But her children have helped her get through this difficult time in her life.

Learn more about MD Anderson in Sugar Land: https://www.mdanderson.org/abo....ut-md-anderson/our-l

Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/Requ....estAppointment?cmpid

Metastatic breast cancer is a stage of breast cancer that has moved to other parts of the body. Eric P. Winer, MD, director of Breast Oncology at the Susan F. Smith Center for Women's Cancers describes metastatic breast cancer symptoms and treatment options. To learn more about how Dana-Farber treats metastatic breast cancer, visit http://www.dana-farber.org/Adu....lt-Care/Treatment-an


Transcription:


Text: What is metastatic breast cancer? What is the prognosis? How is it treated?

Dr. Winer: When we talk about metastatic breast cancer, we’re talking about a stage of breast cancer. Whether a woman has triple negative breast cancer or estrogen receptor positive breast cancer or HER2-positive breast cancer, there is the possibility that that cancer can spread or metastasize, and that means that the cancer moves to other parts of the body, such as the bones, the lungs, the liver, the brain, or a whole variety of other sites.

Text: What is the prognosis?

Dr. Winer: Women who have metastatic breast cancer can live with it for many years—in some cases many, many, many years—but ultimately it is something that can threaten a woman’s life, and at this point in time, we do not have therapy for women with metastatic breast cancer that can reliably eliminate the cancer and allow a woman to live without treatment and to live a normal lifespan.

Text: How is it treated?

Dr. Winer: The way we treat metastatic breast cancer very much depends on the subtype of cancer. We treat estrogen receptor positive metastatic breast cancer differently from estrogen receptor negative metastatic breast cancer, and we have an entirely different set of treatment approaches for HER2-positive breast cancer. Many of our clinical trials focus on women who have metastatic breast cancer, and we are actively looking at new treatments for women with metastatic breast cancer with the idea that treatments that work in this setting may then ultimately be used in women with earlier-stage breast cancer as well with the goal of preventing them from ever developing metastatic breast cancer.

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community